EUVIMEDEUVIMED entdecken
Crossref

De novo design of small molecule–regulated protein oligomers

Qihan Jin iD, Yukai Wang iD, Dachuan Chen iD, Jinyang Liao iD, Zhanyuan Cui iD, Yuxuan Fan iD, Anping Zeng iD, Mingqi Xie iD, Longxing Cao iD

Science · 2026-01 · 391 (6780)

DOI: 10.1126/science.ady6017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2026-01. Verfasst von Qihan Jin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Protein Multimerization, Amantadine, Protein Engineering, Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology, Government of the People’s Republic of Bangladesh, National key R&D program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small molecule–regulated protein oligomerization provides a powerful mechanism for manipulating biological processes by controlling protein proximity with high temporal precision. However, such systems only rarely exist in nature and remain a substantial challenge for de novo design. In this work, we describe a computational method for designing protein homooligomers whose assembly is regulated by small-molecule ligands with matching symmetry. We designed protein homotrimers regulated by the Food and Drug Administration (FDA)–approved drug amantadine and further designed amantadine-responsive heterodimers and heterotrimers. Biophysical characterization confirmed their amantadine-dependent assembly, and their crystal structures closely matched the design models. We demonstrated their broad applicability in controlling protein localization, membraneless condensate formation, and gene expression. Our approach opens new avenues for designing small molecule–responsive proteins and expands the chemogenetic toolkit for manipulating complex biological processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein MultimerizationAmantadineProtein EngineeringProteinsLigandsCrystallography, X-RayProtein ConformationHumansModels, Molecular

Substanzen

AmantadineLigandsProteins

Autor:innen und Institutionen

  • Fudan University, Shanghai, China.
  • State Key Laboratory of Gene Expression, School of Life Sciences and School of Medicine, Westlake University, Hangzhou, Zhejiang, China.
  • Artificial Intelligence Drug Design Core Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
  • Institute of Biology, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.
  • School of Engineering, Westlake University, Hangzhou, China.
  • Center of Synthetic Biology and Integrated Bioengineering, School of Engineering, Westlake University, 600 Dunyu Road, Xihu District, Hangzhou, Zhejiang Province, China.

ORCID-Profile: Qihan Jin, Yukai Wang, Dachuan Chen, Jinyang Liao, Zhanyuan Cui, Yuxuan Fan, Anping Zeng, Mingqi Xie, Longxing Cao

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology, Government of the People’s Republic of Bangladesh
  • National key R&D program of China

Zitieren

APA

Jin, Q., Wang, Y., Chen, D., Liao, J., Cui, Z., Fan, Y., Zeng, A., Xie, M., & Cao, L. (2026). De novo design of small molecule–regulated protein oligomers. Science, 391(6780). https://doi.org/10.1126/science.ady6017

Vancouver

Jin Q, Wang Y, Chen D, Liao J, Cui Z, Fan Y, et al. De novo design of small molecule–regulated protein oligomers. Science. 2026;391(6780). doi:10.1126/science.ady6017

BibTeX
@article{Jin2026,
  author = {Jin, Qihan and Wang, Yukai and Chen, Dachuan and Liao, Jinyang and Cui, Zhanyuan and Fan, Yuxuan and Zeng, Anping and Xie, Mingqi and Cao, Longxing},
  title = {De novo design of small molecule–regulated protein oligomers},
  journal = {Science},
  year = {2026},
  volume = {391},
  number = {6780},
  doi = {10.1126/science.ady6017}
}
Kostenlos starten →